Valuation: Carlsmed, Inc.

Market Cap 477M 435M 401M 364M 684M 44.21B 719M 4.88B 1.94B 24.14B 1.79B 1.75B 75.78B P/E 2026 *
-11.2x
P/E 2027 * -11.3x
Enterprise Value 477M 435M 401M 364M 684M 44.21B 719M 4.88B 1.94B 24.14B 1.79B 1.75B 75.78B EV / Sales 2026 *
6.02x
EV / Sales 2027 * 4.27x
Free-Float
56.65%
Yield 2026 *
-
Yield 2027 * -
1 day+1.16%
1 week+1.75%
Current month+16.52%
1 month+21.73%
3 months+8.54%
6 months+37.71%
Current year+41.05%
1 week 16.8
Extreme 16.8
18.6
1 month 14.01
Extreme 14.01
19.15
Current year 8.5
Extreme 8.5
19.15
1 year 8.5
Extreme 8.5
19.15
3 years 8.5
Extreme 8.5
19.15
5 years 8.5
Extreme 8.5
19.15
10 years 8.5
Extreme 8.5
19.15
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 50 03/06/2018
Chief Executive Officer 50 03/06/2018
Director of Finance/CFO 55 27/09/2026
Director TitleAgeSince
Chairman 50 03/06/2018
Director/Board Member 50 03/06/2018
Director/Board Member 66 15/12/2020
Date Insider Type Main position Quantity % Market Cap. Importance
03/11/26 Exercice

Chief Operating Officer

2,241 0.0084%
30/10/26 Exercice

Chief Operating Officer

729 0.0027%
05/10/26 Exercice

Chief Operating Officer

2,241 0.0084%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+1.75%+39.47% - 477M
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
Average -0.97%-2.19%-4.35%+19.00% 77B
Weighted average by Cap. -1.04%-2.96%-12.41%+15.68%

Financials

2026 *2027 *
Net sales 79.32M 72.24M 66.57M 60.55M 114M 7.35B 119M 810M 322M 4.01B 298M 291M 12.59B 112M 102M 93.87M 85.39M 160M 10.36B 168M 1.14B 454M 5.66B 420M 411M 17.75B
Net income -42.17M -38.41M -35.39M -32.19M -60.39M -3.9B -63.47M -431M -171M -2.13B -158M -155M -6.69B -42.61M -38.81M -35.76M -32.53M -61.02M -3.95B -64.13M -435M -173M -2.16B -160M -156M -6.76B
Net Debt - -
Projected Income Statement - Annual - Carlsmed, Inc.
Logo Carlsmed, Inc.
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Employees
127
Date Price Change Volume
20/11/26 US$17.42 +1.16% 261,688
19/11/26 US$17.22 -0.86% 95,465
18/11/26 US$17.37 -2.09% 188,241
17/11/26 US$17.74 +2.25% 292,412
16/11/26 US$17.35 +1.34% 191,031
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Carlsmed, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.42USD
Average target price
22.00USD
Spread / Average Target
+26.29%
  1. Stock Market
  2. Stocks
  3. CARL Stock